Page last updated: 2024-08-17

cytidine and Respiratory Syndrome, Acute, Severe

cytidine has been researched along with Respiratory Syndrome, Acute, Severe in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dolgin, E1
Barnard, DL; Burton, J; Hubbard, VD; Morrey, JD; Otto, MJ; Sidwell, RW; Smee, DF1

Other Studies

2 other study(ies) available for cytidine and Respiratory Syndrome, Acute, Severe

ArticleYear
The race for antiviral drugs to beat COVID - and the next pandemic.
    Nature, 2021, Volume: 592, Issue:7854

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Birds; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Development; Drug Industry; Europe; Humans; Hydroxylamines; Indoles; Influenza, Human; Leucine; Orthomyxoviridae; Pandemics; Pyrrolidinones; Severe Acute Respiratory Syndrome; Strategic Stockpile; United States

2021
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.
    Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:1

    Topics: Animals; Chlorocebus aethiops; Cytidine; Glycoproteins; Molecular Structure; Nucleosides; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells; Virus Replication

2004